358 related articles for article (PubMed ID: 1434990)
1. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E
Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990
[TBL] [Abstract][Full Text] [Related]
2. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
Thiery J; Seidel D
Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia.
Moriarty P; Sosland R; Gibson C; Belmont J
Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521
[TBL] [Abstract][Full Text] [Related]
4. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
[TBL] [Abstract][Full Text] [Related]
5. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
[TBL] [Abstract][Full Text] [Related]
6. One year experience with a low density lipoprotein apheresis system.
Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
[TBL] [Abstract][Full Text] [Related]
7. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
Bosch T; Lennertz A; Schenzle D; Dräger J;
J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
[TBL] [Abstract][Full Text] [Related]
8. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.
Mol MJ; Stalenhoef AF
Neth J Med; 1990 Jun; 36(5-6):279-87. PubMed ID: 2395495
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of homozygous familial hypercholesterolemia with LDL-apheresis on a 4-year-old child].
Lefort B; Giraud C; Saulnier JP; Bott L; Gambert C; Sosner P; Hankard R
Arch Pediatr; 2009 Dec; 16(12):1554-8. PubMed ID: 19766469
[TBL] [Abstract][Full Text] [Related]
10. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
Lee WP; Datta BN; Ong BB; Rees A; Halcox J
Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.
Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B
Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695
[TBL] [Abstract][Full Text] [Related]
12. Is lipoprotein (a)-apheresis useful?
Bambauer R
Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
[TBL] [Abstract][Full Text] [Related]
13. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
Koizumi J; Koizumi I; Uno Y; Inazu A; Kajinami K; Haraki T; Yagi K; Kamon N; Miyamoto S; Takegoshi T
Atherosclerosis; 1993 Apr; 100(1):65-74. PubMed ID: 8318064
[TBL] [Abstract][Full Text] [Related]
14. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of LDL-apheresis on cholesterol oxidation products and antioxidants in plasma and lipoproteins of patients with familial hypercholesterolemia.
Linseisen J; Wilhelm M; Hoffmann J; Hailer S; Keller C; Wolfram G
Eur J Med Res; 1999 Oct; 4(10):433-41. PubMed ID: 10527957
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial.
Tasaki H; Yamashita K; Saito Y; Bujo H; Daida H; Mabuchi H; Tominaga Y; Matsuzaki M; Fukunari K; Nakazawa R; Tsuji M; Kawade Y; Yamamoto S; Ueda Y; Takayama K
Ther Apher Dial; 2006 Feb; 10(1):32-41. PubMed ID: 16556134
[TBL] [Abstract][Full Text] [Related]
17. LDL apheresis: a novel technique (LIPOCOLLECT 200).
Stefanutti C; Di Giacomo S; Mazzarella B; Castelli A
Artif Organs; 2009 Dec; 33(12):1103-8. PubMed ID: 19995360
[TBL] [Abstract][Full Text] [Related]
18. LDL apheresis in a homozygous familial hypercholesterolemic child aged 4.5.
Stefanutti C; Notarbartolo A; Colloridi V; Nigri A; Vivenzio A; Bertolini S; Bosco G; Berni A; Di Giacomo S; Mazzarella B
Artif Organs; 1997 Oct; 21(10):1126-7. PubMed ID: 9335372
[TBL] [Abstract][Full Text] [Related]
19. Changes in lipoprotein(a), LDL-cholesterol and apolipoprotein B in homozygous familial hypercholesterolaemic patients treated with dextran sulfate LDL-apheresis.
Lasunción MA; Teruel JL; Alvarez JJ; Carrero P; Ortuño J; Gómez-Coronado D
Eur J Clin Invest; 1993 Dec; 23(12):819-26. PubMed ID: 8143758
[TBL] [Abstract][Full Text] [Related]
20. Composition and immunoreactivity of serum low density lipoproteins (LDL) before and after LDL-apheresis on dextran sulfate-cellulose columns.
Gandjini H; Gambert P; Athias A; Mousson C; Rifle G; Lallemant C
Transfus Sci; 1994 Sep; 15(3):289-97. PubMed ID: 10155547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]